Search Results 911-920 of 14778 for anti-TNF drugs

  1. Chemotherapy and sex: Is sexual activity OK during treatment? - Mayo Clinic

    Cancers of the genital tract, urinary tract, anus or rectum may require special caution when it comes to sex. After a procedure or therapy that affects these ...

  2. Chronic lymphocytic leukemia - Diagnosis and treatment - Mayo Clinic

    Learn about this cancer that forms in white blood cells called lymphocytes. Treatments include chemotherapy, targeted therapy and immunotherapy.

  3. Fluorometholone (Ophthalmic Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Nadolol And Bendroflumethiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Conivaptan (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Trastuzumab And Hyaluronidase-Oysk (Subcutaneous Route) Proper Use - Mayo Clinic

    Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...

  7. Rheumatology - Overview - Mayo Clinic

    Rheumatologists at Mayo Clinic work in a team environment to provide state-of-the-art diagnosis and treatment for autoimmune and inflammatory diseases that ...

  8. Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects.

  9. Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used after an initial treatment plan to treat HER2-positive early breast cancer which has a high risk of occurring again.

  10. Selinexor Treatment of Refractory Myeloma - Mayo Clinic

    ... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...